Analyst Price Targets — ICUI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 20, 2026 11:36 am | — | Piper Sandler | $178.00 | $149.74 | TheFly | ICU Medical price target raised to $178 from $172 at Piper Sandler |
| February 20, 2026 11:31 am | Brett Fishbin | KeyBanc | $180.00 | $149.74 | TheFly | ICU Medical price target raised to $180 from $175 at KeyBanc |
| October 21, 2025 10:41 am | Brett Fishbin | KeyBanc | $173.00 | $117.34 | TheFly | ICU Medical price target lowered to $173 from $191 at KeyBanc |
| September 10, 2025 10:42 am | Jason Bednar | Piper Sandler | $153.00 | $132.74 | TheFly | ICU Medical price target raised to $153 from $145 at Piper Sandler |
| August 15, 2025 11:07 am | Jason Bednar | Piper Sandler | $145.00 | $119.32 | TheFly | Piper Sandler bullish on ICU Medical, initiates with an Overweight |
| March 12, 2025 9:12 am | Strong Buy | Raymond James | $97.00 | $138.99 | TheFly | ICU Medical upgraded to Strong Buy from Outperform at Raymond James |
| October 15, 2024 6:32 am | Brett Fishbin | KeyBanc | $198.00 | $180.30 | TheFly | ICU Medical price target raised to $198 from $147 at KeyBanc |
| October 14, 2024 12:54 am | Michael Toomey | Jefferies | $183.00 | $178.72 | StreetInsider | Jefferies Starts ICU Medical (ICUI) at Hold |
| June 17, 2024 3:38 am | Jayson Bedford | Raymond James | $135.00 | $117.44 | StreetInsider | Raymond James Upgrades ICU Medical (ICUI) to Outperform |
| August 9, 2022 8:11 am | — | Raymond James | $190.00 | $188.10 | Benzinga | Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $190 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ICUI

SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences:

ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ICU Medical (ICUI) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $2.11 per share a year ago.

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
